Suicide gene therapy on LNCaP human prostate cancer cells

scientific article published in July 2001

Suicide gene therapy on LNCaP human prostate cancer cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1046/J.1442-2042.2001.00327.X
P698PubMed publication ID11442669
P5875ResearchGate publication ID11897975

P2093author name stringYoshimura I
Suzuki S
Tadakuma T
Hayakawa M
P2860cites workDouble suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitizationQ40780995
RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypesQ40988230
In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectorsQ41019039
Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapiesQ45885920
Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal tumor cellsQ45886533
P433issue7
P921main subjectgene therapyQ213901
P304page(s)S5-8
P577publication date2001-07-01
P1433published inInternational Journal of UrologyQ15767019
P1476titleSuicide gene therapy on LNCaP human prostate cancer cells
P478volume8

Reverse relations

cites work (P2860)
Q39998447ATRA enhances bystander effect of suicide gene therapy in the treatment of prostate cancer
Q40416863Antitumor effects and radiosensitization of cytosine deaminase and thymidine kinase fusion suicide gene on colorectal carcinoma cells
Q45870274Antitumor effects of cytosine deaminase and thymidine kinase fusion suicide gene under the control of mdr1 promoter in mdr1 positive leukemia cells
Q40608060Comparison of different methods to assess the cytotoxic effects of cytosine deaminase and thymidine kinase gene therapy
Q40036198Development of an adenoviral vector with robust expression driven by p53.
Q34557622Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase.
Q36534930Frontiers in Suicide Gene Therapy of Cancer
Q45858785Nonviral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate cancer in vivo
Q38295983Targeted prodrug approaches for hormone refractory prostate cancer.
Q36519354The kallikrein world: an update on the human tissue kallikreins
Q24791038Transcriptional Targeting in Cancer Gene Therapy
Q40262672Two-step transcriptional amplification-lipid-based nanoparticles using PSMA or midkine promoter for suicide gene therapy in prostate cancer

Search more.